Bionano Announces Publication Demonstrating Utility of OGM as an Alternative to KT and CMA for Evaluating CRISPR-Edited Cells as Part of Stem Cell Therapy Development
30 août 2023 08h00 HE
|
Bionano Genomics
SAN DIEGO, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a publication in Nature Communications demonstrating the utility of optical genome mapping (OGM) as...
Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health
28 août 2023 08h00 HE
|
Bionano Genomics
Bionano original equipment manufacturing (OEM) partner A-smart MedTech (A-smart) obtained reagent class I registration and approval for DNA isolation and labeling kits for optical genome mapping (OGM)...
Bionano Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
21 août 2023 16h05 HE
|
Bionano Genomics
SAN DIEGO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has received a letter from the staff of the Listing Qualifications department of the Nasdaq...
Bionano Laboratories Receives College of American Pathologists (CAP) Accreditation for its Clinical Laboratory
16 août 2023 08h00 HE
|
Bionano Genomics
SAN DIEGO, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories, a laboratory services business of Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that it has received Laboratory...
Bionano Announces CFO Transition and Appointment of Gülsen Kama as Chief Financial Officer
14 août 2023 08h00 HE
|
Bionano Genomics
SAN DIEGO, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Gülsen Kama will serve as its next Chief Financial Officer (CFO), effective September 11,...
Bionano Announces Presentation of Optical Genome Mapping (OGM) Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting
11 août 2023 08h00 HE
|
Bionano Genomics
Dr. Alka Chaubey, chief medical officer at Bionano, will host a sponsored vendor panel presentation on the integration of OGM for clinical research in cancer, featuring cancer genomics experts Dr....
Bionano Reports Second Quarter 2023 Results and Highlights Recent Business Progress
09 août 2023 16h01 HE
|
Bionano Genomics
Q2 2023 revenue was $8.7 million, which represents a 30% increase over Q2 2022Installed base of Saphyr® systems totaled 281 as of June 30, 2023, which represents a 43% increase over Q2 2022Sold 7,062...
Bionano Genomics Announces Reverse Stock Split
04 août 2023 12h00 HE
|
Bionano Genomics
SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that the Company effected a reverse stock split of its issued and outstanding common stock, at a...
Bionano to Report Second Quarter 2023 Financial Results and Host a Conference Call and Webcast on August 9, 2023
02 août 2023 08h00 HE
|
Bionano Genomics
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, August 9, 2023, at 4:30 p.m....
Bionano Announces OGM Roadshow, TOUR, which Provides Education on the Company’s Workflow and Helps Build a Community of Users
31 juil. 2023 08h00 HE
|
Bionano Genomics
SAN DIEGO, July 31, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the successful launch of its optical genome mapping (OGM) roadshow, Bionano TOUR, a series of...